Wolf‐Rüdiger Ulrich

The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance

Volker Gekeler, W Ise, Karl H. Sanders et al. · Biochemical and Biophysical Research Communications · 1995 · 405 citations

Inflammation, Molecular Pharmacology, Anti-inflammatory +9

The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes

Rainer Boer, Wolf‐Rüdiger Ulrich, Thomas Klein et al. · Molecular Pharmacology · 2000 · 154 citations

The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase

Andreas Strub, Wolf‐Rüdiger Ulrich, Christian Heßlinger et al. · Molecular Pharmacology · 2005 · 35 citations

Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights

Ulrich Grädler, Thomas Fuchß, Wolf‐Rüdiger Ulrich et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 33 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +9

Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry

Christoph H. Borchers, Rainer Boer, Kurt Klemm et al. · Molecular Pharmacology · 2002 · 33 citations